Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Sep-24 4:20 PM View:  | Dong-A St Co., Ltd 10% Owner | Neurobo Pharmaceuticals, Inc. (NRBO) | 12-Sep-24 | Sale | 407 | $3.75 | $1,526.25 | (< 1%) 5.35M to 5.35M | |
| 13-Aug-24 4:01 PM View: | Kim Hyung Heon CEO & President Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 11-Aug-24 | Payment of Exercise | 11,467 | $3.60 | $41,281.20 | (15%) 78.13K to 66.67K | |
| 25-Jun-24 4:16 PM View: | Dong-A St Co., Ltd 10% Owner | Neurobo Pharmaceuticals, Inc. (NRBO) | 23-Jun-24 | Private Purchase | 2,544,530 | $3.13 | $7,964,380.00 | 91% 2.8M to 5.35M | |
| 07-Jun-24 7:25 PM View: | Koven Andrew I Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 07-Jun-24 | Grant | 5,051 | -- | -- | 40% 12.5K to 17.55K | |
| 07-Jun-24 7:26 PM View: | Salsbury Michael Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 07-Jun-24 | Grant | 5,051 | -- | -- | 40% 12.5K to 17.55K | |
| 07-Jun-24 7:25 PM View: | Glickman Mark A Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 07-Jun-24 | Grant | 5,051 | -- | -- | 108% 4.69K to 9.74K | |
| 07-Jun-24 7:26 PM View: | Groves Jason L Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 07-Jun-24 | Grant | 5,051 | -- | -- | 40% 12.5K to 17.55K | |
| 07-Jun-24 7:24 PM View: | Strickland D Gordon Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 07-Jun-24 | Grant | 5,051 | -- | -- | 40% 12.5K to 17.55K | |
| 07-Jun-24 7:24 PM View: | Tursi James Patrick Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 07-Jun-24 | Grant | 5,051 | -- | -- | 126% 4.02K to 9.07K | |
| 04-Mar-24 9:20 PM View: | Woodworth Marshall H Chief Financial Officer | Neurobo Pharmaceuticals, Inc. (NRBO) | 01-Mar-24 | Grant | 33,496 | -- | -- | 100% 0 to 33.5K | |
| 04-Dec-23 5:12 PM View: | Tursi James Patrick Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 01-Dec-23 | Grant | 32,157 | -- | -- | 100% 0 to 32.16K | |
| 14-Aug-23 4:10 PM View: | Kim Hyung Heon CEO & President Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 11-Aug-23 | Grant | 625,064 | -- | -- | 100% 0 to 625.06K | |
| 28-Jul-23 6:17 AM View: | Salsbury Michael Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 27-Jul-23 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 28-Jul-23 6:11 AM View: | Glickman Mark A Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 27-Jul-23 | Grant | 37,500 | -- | -- | 100% 0 to 37.5K | |
| 28-Jul-23 6:13 AM View: | Groves Jason L Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 27-Jul-23 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 28-Jul-23 6:15 AM View: | Strickland D Gordon Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 27-Jul-23 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 28-Jul-23 6:08 AM View: | Kim Na Yeon Director 10% Owner | Neurobo Pharmaceuticals, Inc. (NRBO) | 27-Jul-23 | Grant | 100,000 | -- | -- | 50% 202.01K to 302.01K | |
| 28-Jul-23 6:19 AM View: | Koven Andrew I Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 27-Jul-23 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 28-Jul-22 9:23 PM View: | E&investment, Inc. 10% Owner | Neurobo Pharmaceuticals, Inc. (NRBO) | 26-Jul-22 | Disposition (other) Duplicate | 1,445,270 | -- | -- | (19%) 7.46M to 6.02M | |
| 28-Jul-22 4:03 PM View: | Kim Na Yeon Director 10% Owner | Neurobo Pharmaceuticals, Inc. (NRBO) | 26-Jul-22 | Disposition (other) | 1,445,270 | -- | -- | (20%) 7.37M to 5.92M | |
| 05-Jan-21 4:09 PM View: | Bakshi Akash SVP and COO Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 31-Dec-20 | Grant | 29,013 | -- | -- | 100% 29.01K to 58.03K | |
| 05-Jan-21 4:09 PM View: | Bakshi Akash SVP and COO Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 31-Dec-20 | Grant | 855,059 | -- | -- | 1474% 58.03K to 913.09K | |
| 02-Jan-20 9:53 PM View: | Oh Jeong Gyun Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 30-Dec-19 | Grant | 2,057,890 | -- | -- | 100% 0 to 2.06M | |
| 02-Jan-20 9:52 PM View: | Kim Na Yeon Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 30-Dec-19 | Grant | 7,321,790 | -- | -- | 100% 0 to 7.32M | |
| 26-Jul-19 4:10 PM View: | Bisgaier Charles Phd Chief Scientific Off. & Chair Director 10% Owner | Neurobo Pharmaceuticals, Inc. (NRBO) | 24-Jul-19 | Grant | 100,000 | -- | -- | 7% 1.35M to 1.45M | |
| 26-Jul-19 4:24 PM View: | Kousky Kenneth W Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 24-Jul-19 | Grant | 15,000 | -- | -- | 126% 11.94K to 26.93K | |
| 26-Jul-19 4:38 PM View: | Sassine Andy Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 24-Jul-19 | Grant | 15,000 | -- | -- | 11% 136.26K to 151.26K | |
| 26-Jul-19 4:16 PM View: | Reno Seth Chief Commercial Officer | Neurobo Pharmaceuticals, Inc. (NRBO) | 24-Jul-19 | Grant | 100,000 | -- | -- | 547% 18.29K to 118.29K | |
| 26-Jul-19 4:01 PM View: | Gullans Steven R. Ph.D. President & CEO Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 24-Jul-19 | Grant | 300,000 | -- | -- | 100% 0 to 300.0K | |
| 26-Jul-19 4:30 PM View: | Lichtinger Pedro Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 24-Jul-19 | Grant | 15,000 | -- | -- | 25% 59.83K to 74.83K | |
| 12-Feb-18 10:00 PM View: | Gullans Steven R. Ph.D. Interim President & CEO Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 08-Feb-18 | Market Purchase | 71,429 | $7.00 | $500,003.00 | 8% 858.82K to 930.25K | (96%) |
| 12-Feb-18 4:40 PM View: | Reno Seth Chief Commercial Officer | Neurobo Pharmaceuticals, Inc. (NRBO) | 08-Feb-18 | Market Purchase | 14,286 | $7.00 | $100,002.00 | 357% 4.0K to 18.29K | (96%) |
| 16-Aug-17 4:10 PM View: | Mathiesen Jeffrey S Chief Financial Officer | Neurobo Pharmaceuticals, Inc. (NRBO) | 14-Aug-17 | Option Exercise | 3,207 | $3.59 | $11,513.10 | 29% 10.93K to 14.13K | |
| 11-Aug-17 4:07 PM View: | Mathiesen Jeffrey S Chief Financial Officer | Neurobo Pharmaceuticals, Inc. (NRBO) | 10-Aug-17 | Option Exercise | 3,000 | $3.59 | $10,770.00 | 38% 7.93K to 10.93K | |
| 02-Aug-17 4:11 PM View: | Bisgaier Charles Phd Chief Scientific Off. & Chair Director 10% Owner | Neurobo Pharmaceuticals, Inc. (NRBO) | 31-Jul-17 | Option Exercise | 4,474 | $1.34 | $6,013.06 | < 1% 1.35M to 1.35M | |
| 14-Mar-17 6:07 PM View: | Sassine Andy Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 10-Mar-17 | Market Purchase | 21,119 | $9.47 | $199,997.00 | 18% 115.14K to 136.26K | (97%) |
| 14-Mar-17 5:33 PM View: | Gullans Steven R. Ph.D. Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 10-Mar-17 | Market Purchase | 52,798 | $9.47 | $499,997.00 | 7% 806.02K to 858.82K | (97%) |
| 14-Mar-17 5:46 PM View: | Hawryluk P. Kent Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 10-Mar-17 | Market Purchase | 25,000 | $9.47 | $236,750.00 | 28% 88.95K to 113.95K | (97%) |
| 14-Mar-17 5:57 PM View: | Lichtinger Pedro Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 10-Mar-17 | Market Purchase | 10,559 | $9.47 | $99,993.70 | 21% 49.27K to 59.83K | (97%) |
| 03-Feb-17 4:25 PM View: | Kousky Kenneth W Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 01-Feb-17 | Disposition (other) | 211,834 | -- | -- | (95%) 223.77K to 11.94K | |
| 12-Aug-16 12:56 PM View: | Oniciu Carmen Daniela Vice President | Neurobo Pharmaceuticals, Inc. (NRBO) | 10-Aug-16 | Conversion | 2,237 | -- | -- | 1% 149.92K to 152.16K | |
| 12-Aug-16 1:06 PM View: | Reno Seth Chief Commercial Officer | Neurobo Pharmaceuticals, Inc. (NRBO) | 10-Aug-16 | Purchase | 4,000 | $10.00 | $40,000.00 | 100% 0 to 4.0K | |
| 12-Aug-16 1:09 PM View: | Gullans Steven R. Ph.D. Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 10-Aug-16 | Purchase | 500,000 | $10.00 | $5,000,000.00 | 163% 306.02K to 806.02K | |
| 12-Aug-16 1:27 PM View: | Hawryluk P. Kent Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 10-Aug-16 | Acquisition (other) | 816 | $6.71 | $5,472.01 | 1% 63.13K to 63.95K | |
| 12-Aug-16 1:19 PM View: | Lichtinger Pedro Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 10-Aug-16 | Conversion | 39,274 | $6.71 | $263,368.00 | 100% 0 to 39.27K | |
| 12-Aug-16 12:47 PM View: | Bisgaier Charles Phd Chair & Chief Scientific Off. Director 10% Owner | Neurobo Pharmaceuticals, Inc. (NRBO) | 10-Aug-16 | Purchase | 51,750 | $10.00 | $517,500.00 | 4% 1.29M to 1.35M | |
| 12-Aug-16 1:01 PM View: | Sooch Mina President & CEO Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 10-Aug-16 | Acquisition (other) | 1,212 | $6.71 | $8,127.55 | < 1% 679.45K to 680.66K | |
| 12-Aug-16 12:56 PM View: | Oniciu Carmen Daniela Vice President | Neurobo Pharmaceuticals, Inc. (NRBO) | 10-Aug-16 | Acquisition (other) | 245 | $6.71 | $1,642.95 | < 1% 152.16K to 152.4K | |
| 12-Aug-16 1:27 PM View: | Hawryluk P. Kent Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 10-Aug-16 | Purchase | 25,000 | $10.00 | $250,000.00 | 39% 63.95K to 88.95K | |
| 12-Aug-16 1:15 PM View: | Kousky Kenneth W Director | Neurobo Pharmaceuticals, Inc. (NRBO) | 10-Aug-16 | Conversion | 212,330 | $3.69 | $783,859.00 | 100% 0 to 212.33K |
